Dr. Adam Brufsky presents: "New and Upcoming Treatments in Breast Cancer."

Dr. Adam Brufsky presents: "New and Upcoming Treatments in Breast Cancer."Подробнее

Dr. Adam Brufsky presents: 'New and Upcoming Treatments in Breast Cancer.'

Advances in Breast Cancer Care | UPMCПодробнее

Advances in Breast Cancer Care | UPMC

Improvements in Breast Cancer Treatment - Dr. Adam Brufsky ASCO 2014Подробнее

Improvements in Breast Cancer Treatment - Dr. Adam Brufsky ASCO 2014

Dr Adam Brufsky Discusses Value Coordinates of Breast Cancer CareПодробнее

Dr Adam Brufsky Discusses Value Coordinates of Breast Cancer Care

Dr. Brufsky on Challenges in Breast CancerПодробнее

Dr. Brufsky on Challenges in Breast Cancer

Case Study: HER2+ Breast Cancer in a 62-year-old FemaleПодробнее

Case Study: HER2+ Breast Cancer in a 62-year-old Female

Adam Brufsky, MD, PhD, describes the treatment landscape of HER2+ metastatic breast cancerПодробнее

Adam Brufsky, MD, PhD, describes the treatment landscape of HER2+ metastatic breast cancer

Adam Brufsky, MD, PhD: Considerations for Different Therapies in Breast CancerПодробнее

Adam Brufsky, MD, PhD: Considerations for Different Therapies in Breast Cancer

Adam Brufsky, MD, PhD: Expectations of Therapy in Breast CancerПодробнее

Adam Brufsky, MD, PhD: Expectations of Therapy in Breast Cancer

Adam Brufsky, MD, PhD: Choices of Therapy in Breast CancerПодробнее

Adam Brufsky, MD, PhD: Choices of Therapy in Breast Cancer

Dr Adam Brufsky: Choosing a Therapy for Breast Cancer PatientsПодробнее

Dr Adam Brufsky: Choosing a Therapy for Breast Cancer Patients

Dr Adam Brufsky Outlines Care Coordination in OncologyПодробнее

Dr Adam Brufsky Outlines Care Coordination in Oncology

Dr. Brufsky Advises Doctors on Bevacizumab for Breast CancerПодробнее

Dr. Brufsky Advises Doctors on Bevacizumab for Breast Cancer

Adam Brufsky, MD, PhD, considers the investigation of poziotinib in HER2+ metastatic breast cancerПодробнее

Adam Brufsky, MD, PhD, considers the investigation of poziotinib in HER2+ metastatic breast cancer

Dr. Brufsky on Multiparametric Genomic Assays in Breast CancerПодробнее

Dr. Brufsky on Multiparametric Genomic Assays in Breast Cancer

Dr. Brufsky on Challenges Facing Biosimilars in Breast CancerПодробнее

Dr. Brufsky on Challenges Facing Biosimilars in Breast Cancer

Adam Brufsky, MD, PhD: Choices of TherapyПодробнее

Adam Brufsky, MD, PhD: Choices of Therapy

Dr. Brufsky Discusses Future Research into BisphosphonatesПодробнее

Dr. Brufsky Discusses Future Research into Bisphosphonates

Oncology Today with Dr Neil Love: Understanding the Risk of Recurrence and Related Management for...Подробнее

Oncology Today with Dr Neil Love: Understanding the Risk of Recurrence and Related Management for...

Dr. Brufsky on Genomic Assays for Breast CancerПодробнее

Dr. Brufsky on Genomic Assays for Breast Cancer

An Overview of Immunotherapy in Breast Cancer - An Interview with Adam BrufskyПодробнее

An Overview of Immunotherapy in Breast Cancer - An Interview with Adam Brufsky